# EDGAR Filing Document

**Accession Number:** 0001839133
**File Stem:** 0001641172-25-021381
**Filing Date:** 2025-7
**Character Count:** 10115
**Document Hash:** cb1999b65c110273b6f5fe3e8f9c4fdd
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-021381.hdr.sgml**: 20250729

**ACCESSION NUMBER**: 0001641172-25-021381

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20250723

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250729

**DATE AS OF CHANGE**: 20250729

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** IR-Med, Inc.
- **CENTRAL INDEX KEY:** 0001839133
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 844516398
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-56492
- **FILM NUMBER:** 251162171

**BUSINESS ADDRESS:**
- **STREET 1:** C/O ABOUDI LEGAL GROUP PLLC, 745 5TH AVE
- **STREET 2:** SUITE 500
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10151
- **BUSINESS PHONE:** 6467684285

**MAIL ADDRESS:**
- **STREET 1:** C/O ABOUDI LEGAL GROUP PLLC, 745 5TH AVE
- **STREET 2:** SUITE 500
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10151

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** International Display Advertising, Inc.
- **DATE OF NAME CHANGE:** 20210105

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, DC 20549**

**FORM 8-K**

**CURRENT REPORT PURSUANT**

**TO SECTION 13 OR 15(d) OF THE**

**SECURITIES EXCHANGE ACT OF 1934**

Date of report (Date of earliest event reported): **July 23, 2025**

**IR-MED, INC.**

---

| | | |
|:---|:---|:---|
| **Nevada** | **000-56492** | **84-4516398** |
| (State or Other Jurisdiction | (commission | (IRS Employer |
| Of incorporation) | File Number) | Identification Number) |

---

---

| | |
|:---|:---|
| **ZHR Industrial Zone Rosh Pina Israel** | **1231400** |
| (Address of Principal Executive Offices) | (Area Code) |

---

**+ 972-4-655-5054**

(Registrant's telephone number, including area code)

**Not applicable**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

<u>Title of each class</u> <u>Trading Symbol</u> <u>Name of each exchange on which registered</u> <br> N/A N/A N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 5.02** **Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

 

On July 23, 2025, IR-Med, Inc. (the "Company") entered into a second amendment to the employment agreement with Mr. Sharon Levkoviz, the Company's Chief Financial Officer (the "Amendment").

Pursuant to the terms of the Amendment, the monthly salary of Mr. Levkoviz will be reduced to NIS 7,500 and he will no longer be entitled to the benefit of a leased car or any related payment allowances starting August 1, 2025. In addition, Mr. Levkoviz's scope of employment will be reduced to 25% of his time as of August 1, 2025. All other terms related to Mr. Levkoviz's overall compensation and equity-based awards remain unchanged.

The foregoing description of the Amendment is a summary and is qualified in its entirety by reference to the Amendment, which is filed herewith as Exhibit 10.1 and incorporated by reference herein.

**Item 9.01. Financial Statements and Exhibits.**

(d) Exhibits

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 10.1 | [Second Amendment to Employment Agreement between the Company and Mr. Levkoviz](ex10-1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| IR-Med, Inc. | IR-Med, Inc. |
| By: | */s/ Sharon Lefkoviz* |
| Name: | Sharon Lefkoviz |
| Title: | Chief Financial Officer |

---

Date: July 29, 2025

## Exhibit 10.1

**Exhibit 10.1**

<u>SECOND AMENDMENT TO EMPLOYMENT AGREEMENT</u>

THIS AMENDMENT TO THE EMPLOYMENT AGREEMENT (this "**Amendment**") is made as of July 23rd, 2025 by and among I.R. Med Ltd, an Israeli Company with registration # 514824952, (the "**Company**"), and Sharon Levkoviz ID # 027123751 (the "**employee**").

WHEREAS, the Company and the employee entered into an employment agreement in January ,2021 (the "**Employment Agreement**") and

WHEREAS, the Company and the Employee wish to reduce into writing two amendments to the employment agreement, as approved in January, 2021.

**NOW, THEREFORE**, the parties hereto hereby agree as follows:

---

| | |
|:---|:---|
| **1.** | **To amend the monthly salary to 7,500 NIS starting from August 1<sup>st</sup>,2025** |
|  | Notwithstanding the provisions of Schedule B Section 1 of the Employment Agreement, the Company and the employee hereby agree to amend the monthly gross salary to 7,500 NIS starting from August 1<sup>st</sup>,2025, and forward. In addition, the parties agree that the scope of the Employee's position shall be reduced to 25% as of the same date. |
| **2.** | **To cancel the benefit of the leased car starting from August 1<sup>st</sup>,2025** |
|  | Notwithstanding the provisions of Schedule B, Section 8 of the Employment Agreement, the Company and the Employee hereby agree that, effective as of August 1st, 2025, the Employee shall no longer be entitled to the benefit of a leased car or any related payments or allowances. |
| 3. | **<u>Miscellaneous</u>**. |

---

A. This
 Amendment shall be governed by and construed in accordance with the laws of the State of Israel, excluding the body of law pertaining
 to conflict of law. Any disputes arising under or in relation to this Agreement shall be resolved exclusively by the competent courts
 of Tel-Aviv.

B. Except
 as otherwise expressly limited herein, the provisions hereof shall inure to the benefit of, and be binding upon, the successors,
 assigns, heirs, executors, and administrators of the parties hereto. None of the rights, privileges, or obligations set forth in,

 the employee.

C. This
 Amendment constitutes the full and entire understanding and agreement betweenthe parties with regard to the subject matter hereof
 and thereof, provided however that the Employment Agreement shall continue to be binding upon the parties' and be in full force
 and effect, subject to the changes herein.

D. Any
 term of this Amendment may be amended and the observance of any term hereof may be waived (either prospectively or retroactively
 and either generally or in a particular instance) only by the execution of a written amendment to this Amendment to be signed by
 the parties hereto.

E. All
 notices and other communications required or permitted hereunder to be given to aparty to this Amendment shall be in writing and
 shall be faxed, emailed or mailed by registered or certified mail, postage prepaid, or otherwise delivered by hand or by messenger,
 to the following addresses, or such other address with respect to a party as such party shall notify each other party in writing
 as above provided: (i) if to the Lender, to the addresses set forth in the preamble, and (ii) if to the Company, Tzahar Industrial
 Zone, Rosh Pina 1210002 Email: <u>sharon@ir-medical.com</u> Any notice sent in accordance with this Section shall be effective (i)
 if mailed, five (5) business days after mailing, (ii) if sent by messenger upon delivery and (iii) if sent via fax or email, upon
 transmission and electronic confirmation of receipt or if transmitted and received on a non-business day, on the first business day
 following transmission and electronic confirmation of receipt.

F. No
 delay or omission to exercise any right, power, or remedy accruing to any partyupon any breach or default under this Amendment, shall
 be deemed a waiver of any other breach or default theretofore or thereafter occurring.

G. This
 Amendment may be executed in any number of counterparts, each of which shallbe deemed an original and enforceable against the parties
 actually executing such counterpart, and all of which together shall constitute one and the same instrument. Signatures by facsimile
 or signatures which have been scanned and transmitted by electronic mail shall be deemed valid and binding for all purposes.

**IN WITNESS WHEREOF** the parties have signed this Amendment to the Employment Agreement in one or more counterparts as of the date first herein above set forth.

---

| | |
|:---|:---|
| <u>Company:</u> | <u>Company:</u> |
| **I.R. Med Ltd.** | **I.R. Med Ltd.** |
|  | */s/ Ran Ziskind* |
| By: | Ran Ziskind |
| Title: | CEO |

---

---

| |
|:---|
| <u>Employee:</u> |
| */s/ Sharon Levkoviz* |
| **Sharon Levkoviz** |

---